SCHEMBL9263095

SCHEMBL9263095

COc1ccc(OC)c(S(=O)(=O)Nc2ccc(-n3cnc(C)c3)c(OC)c2)c1

nearest known ligand 0.67

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
▸ PSEN1 P49768 2/20 0.67
▸ PSEN2 P49810 2/20 0.67
▸ APH1B Q8WW43 2/20 0.67
▸ NCSTN Q92542 2/20 0.67
▸ APH1A Q96BI3 2/20 0.67
▸ PSENEN Q9NZ42 2/20 0.67
▸ ALDH1A1 P00352 2/20 0.58
▸ NPSR1 Q6W5P4 1/20 0.58
▸ TP53 P04637 2/20 0.56
▸ POLB P06746 1/20 0.56
▸ SMN1; SMN2 Q16637 6/20 0.55
▸ ALPL P05186 3/20 0.54
▸ MEN1 O00255 2/20 0.52
▸ KMT2A Q03164 2/20 0.52
▸ LMNA P02545 2/20 0.52
▸ ALOX12 P18054 1/20 0.52
▸ TRIM24 O15164 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8819265 0.92 PSEN1 (0.67) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL9263624 0.91 PSEN1 (0.68) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8819517 0.87 PSEN1 (0.69) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8817879 0.84 PSEN1 (0.60) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8817371 0.84 PSEN1 (0.68) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL9264936 0.83 PSEN1 (0.79) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL9260640 0.82 PSEN1 (0.60) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL9264176 0.82 PSEN1 (0.66) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL8819732 0.82 PSEN1 (0.72) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6122402 0.82 PSEN1 (0.66) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120135997-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND SHIONOGI & CO., LTD. (JP) 2012-05-31 — — US disclosed
US-20120135997-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND SHIONOGI & CO., LTD. (JP) 2012-05-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120135997-A1 PHARMACEUTICAL COMPOSITION COMPRISING A LACTAM OR BENZENESULFONAMIDE COMPOUND BACE1, STS, APP PSEN1 9/4885PSEN2 20/4885APH1B 31/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback